India · Delayed Price · Currency is INR Mukka Proteins Statistics
Total Valuation
Mukka Proteins has a market cap or net worth of INR 7.56 billion. The enterprise value is 15.04 billion.
| Market Cap | 7.56B |
| Enterprise Value | 15.04B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Mukka Proteins has 300.00 million shares outstanding. The number of shares has decreased by -0.27% in one year.
| Current Share Class | 300.00M |
| Shares Outstanding | 300.00M |
| Shares Change (YoY) | -0.27% |
| Shares Change (QoQ) | -0.61% |
| Owned by Insiders (%) | 73.33% |
| Owned by Institutions (%) | 3.97% |
| Float | 80.00M |
Valuation Ratios
The trailing PE ratio is 14.48.
| PE Ratio | 14.48 |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| PB Ratio | 1.43 |
| P/TBV Ratio | 1.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 28.90 |
| EV / Sales | 1.04 |
| EV / EBITDA | 12.90 |
| EV / EBIT | 15.03 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 1.47.
| Current Ratio | 1.23 |
| Quick Ratio | 0.23 |
| Debt / Equity | 1.47 |
| Debt / EBITDA | 6.80 |
| Debt / FCF | -3.12 |
| Interest Coverage | 1.83 |
Financial Efficiency
Return on equity (ROE) is 11.59% and return on invested capital (ROIC) is 6.57%.
| Return on Equity (ROE) | 11.59% |
| Return on Assets (ROA) | 4.54% |
| Return on Invested Capital (ROIC) | 6.57% |
| Return on Capital Employed (ROCE) | 17.13% |
| Weighted Average Cost of Capital (WACC) | 6.54% |
| Revenue Per Employee | 46.16M |
| Profits Per Employee | 1.66M |
| Employee Count | 314 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 1.65 |
Taxes
In the past 12 months, Mukka Proteins has paid 180.57 million in taxes.
| Income Tax | 180.57M |
| Effective Tax Rate | 24.03% |
Stock Price Statistics
The stock price has decreased by -18.12% in the last 52 weeks. The beta is 0.66, so Mukka Proteins's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -18.12% |
| 50-Day Moving Average | 23.14 |
| 200-Day Moving Average | 24.17 |
| Relative Strength Index (RSI) | 66.74 |
| Average Volume (20 Days) | 299,193 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mukka Proteins had revenue of INR 14.49 billion and earned 520.58 million in profits. Earnings per share was 1.74.
| Revenue | 14.49B |
| Gross Profit | 2.80B |
| Operating Income | 979.90M |
| Pretax Income | 751.43M |
| Net Income | 520.58M |
| EBITDA | 1.15B |
| EBIT | 979.90M |
| Earnings Per Share (EPS) | 1.74 |
Balance Sheet
The company has 604.29 million in cash and 7.79 billion in debt, with a net cash position of -7.19 billion or -23.96 per share.
| Cash & Cash Equivalents | 604.29M |
| Total Debt | 7.79B |
| Net Cash | -7.19B |
| Net Cash Per Share | -23.96 |
| Equity (Book Value) | 5.29B |
| Book Value Per Share | 16.70 |
| Working Capital | 2.40B |
Cash Flow
In the last 12 months, operating cash flow was -1.11 billion and capital expenditures -1.38 billion, giving a free cash flow of -2.50 billion.
| Operating Cash Flow | -1.11B |
| Capital Expenditures | -1.38B |
| Depreciation & Amortization | 165.92M |
| Net Borrowing | 3.13B |
| Free Cash Flow | -2.50B |
| FCF Per Share | -8.32 |
Margins
Gross margin is 19.33%, with operating and profit margins of 6.76% and 3.59%.
| Gross Margin | 19.33% |
| Operating Margin | 6.76% |
| Pretax Margin | 5.18% |
| Profit Margin | 3.59% |
| EBITDA Margin | 7.91% |
| EBIT Margin | 6.76% |
| FCF Margin | n/a |
Dividends & Yields
Mukka Proteins does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.27% |
| Shareholder Yield | 0.27% |
| Earnings Yield | 6.89% |
| FCF Yield | -33.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |